Insulin responses to glucose and isoproterenol decrease with age

James M Watters1

  • 1Department of Surgery, University of Ottawa, and Ottawa Health Research Institute, Ottawa Hospital, Ottawa, Ont. jwatters@ohri.ca

Insights

Older adults show reduced heart rate and insulin responses to beta-adrenergic stimulation and glucose loading compared to younger individuals. This suggests impaired beta-adrenergic sensitivity contributes to glucose intolerance in aging.

Area of Science:

  • Endocrinology
  • Gerontology
  • Physiology

Background:

  • Older trauma patients exhibit impaired glucose tolerance, partly due to diminished insulin response.
  • This study investigated if reduced pancreatic sensitivity to beta-adrenergic stimulation underlies these diminished insulin responses in older individuals.

Purpose of the Study:

  • To compare the effects of beta-adrenergic stimulation and glucose loading on insulin response in young versus older healthy adults.
  • To determine if diminished beta-adrenergic sensitivity contributes to age-related glucose intolerance.

Main Methods:

  • Prospective study involving healthy young and older adults undergoing isoproterenol infusion.
  • Paired studies included isoproterenol infusion alone and with a hyperglycemic glucose clamp.
  • Measurements included heart rate, serum insulin, and hemodynamic and physiological variables.

Main Results:

  • Older adults had a less pronounced heart rate increase in response to isoproterenol (p < 0.01).
  • Serum insulin levels during combined infusion and clamp were lower in older adults (467 pmol/L) than in young adults (755 pmol/L) (p < 0.05).
  • Whole-body glucose disposal was significantly lower in older adults (5.8 mg/kg/min) compared to younger adults (9.6 mg/kg/min) (p < 0.05).

Conclusions:

  • Healthy older adults exhibit lower heart rate and serum insulin responses to combined isoproterenol and glucose loading compared to younger individuals.
  • Diminished tissue sensitivity to beta-adrenergic signals may explain the impaired insulin response and glucose intolerance seen in older individuals post-injury or illness.
Abstract

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...